Update: 30.11.2021
Last week: 46th week 2021
Last full month: Oct 2021
| Time period | Volume | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. |
|---|---|---|---|---|---|---|---|---|
| APILAC | ||||||||
| WoW | 1 780 | -6.1% | 46.7% | 1.5 | 783 653 | -4.8% | 76.6% | 1.5 |
| MoM | 9 836 | 8.9% | 52.7% | -1.3 | 4 274 998 | 16.8% | 80.5% | 0.1 |
| YTD | 107 258 | -23.7% | 56.8% | -5 | 41 089 785 | 0.4% | 80.8% | 0.3 |
| MAT | 123 351 | -23.4% | 57.3% | -4 | 46 431 180 | -0.5% | 80.9% | 0.8 |
| CAPSICAM | ||||||||
| WoW | 21 622 | -5.5% | 3.5% | -0.1 | 8 716 286 | -5.5% | 3.7% | -0.1 |
| MoM | 98 655 | 11.0% | 3.3% | 0 | 39 872 483 | 9.4% | 3.5% | 0.1 |
| YTD | 924 153 | -20.6% | 3.2% | -0.3 | 381 694 177 | -5.4% | 3.5% | -0.2 |
| MAT | 1 088 294 | -20.1% | 3.3% | -0.3 | 449 472 537 | -3.3% | 3.6% | -0.1 |
| MILDRONATE | ||||||||
| WoW | 104 715 | -7.6% | 87.2% | 0.8 | 39 993 494 | -7.6% | 90.2% | 0.8 |
| MoM | 475 089 | 22.1% | 86.9% | 2 | 182 644 369 | 20.2% | 89.7% | 1.6 |
| YTD | 4 228 142 | 13.3% | 63.9% | 0.1 | 1 713 110 479 | 21.0% | 68.8% | 1.4 |
| MAT | 4 778 564 | 13.1% | 63.4% | 0 | 1 949 376 898 | 22.2% | 68.5% | 1.6 |
| SULFARGIN | ||||||||
| WoW | 2 705 | -16.1% | 0.8% | -0.1 | 1 359 127 | -15.7% | 1.2% | -0.2 |
| MoM | 13 526 | 3.1% | 0.8% | 0 | 6 782 685 | 2.8% | 1.2% | -0.1 |
| YTD | 142 016 | -24.8% | 0.8% | -0.2 | 68 999 573 | -11.1% | 1.1% | -0.1 |
| MAT | 162 640 | -21.7% | 0.8% | -0.2 | 78 557 277 | -7.4% | 1.2% | -0.1 |
| VIPROSAL | ||||||||
| WoW | 33 450 | -5.3% | 5.4% | -0.1 | 12 811 289 | -5.8% | 5.4% | -0.2 |
| MoM | 143 156 | 17.7% | 4.8% | 0.3 | 53 773 094 | 18.7% | 4.8% | 0.5 |
| YTD | 1 061 459 | -16.0% | 3.6% | -0.1 | 399 585 258 | -5.8% | 3.7% | -0.2 |
| MAT | 1 222 932 | -15.9% | 3.7% | -0.2 | 461 918 444 | -3.7% | 3.7% | -0.1 |
| Brand | Volume | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. |
|---|---|---|---|---|---|---|---|---|
| APILAC | 1 780 | -6.1% | 46.7% | 1.5 | 783 653 | -4.8% | 76.6% | 1.5 |
| CAPSICAM | 21 622 | -5.5% | 3.5% | -0.1 | 8 716 286 | -5.5% | 3.7% | -0.1 |
| MILDRONATE | 104 715 | -7.6% | 87.2% | 0.8 | 39 993 494 | -7.6% | 90.2% | 0.8 |
| SULFARGIN | 2 705 | -16.1% | 0.8% | -0.1 | 1 359 127 | -15.7% | 1.2% | -0.2 |
| VIPROSAL | 33 450 | -5.3% | 5.4% | -0.1 | 12 811 289 | -5.8% | 5.4% | -0.2 |
| Brand | Volume | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. |
|---|---|---|---|---|---|---|---|---|
| APILAC | 9 836 | 8.9% | 52.7% | -1.3 | 4 274 998 | 16.8% | 80.5% | 0.1 |
| CAPSICAM | 98 655 | 11.0% | 3.3% | 0 | 39 872 483 | 9.4% | 3.5% | 0.1 |
| MILDRONATE | 475 089 | 22.1% | 86.9% | 2 | 182 644 369 | 20.2% | 89.7% | 1.6 |
| SULFARGIN | 13 526 | 3.1% | 0.8% | 0 | 6 782 685 | 2.8% | 1.2% | -0.1 |
| VIPROSAL | 143 156 | 17.7% | 4.8% | 0.3 | 53 773 094 | 18.7% | 4.8% | 0.5 |
| Brand | Volume | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. |
|---|---|---|---|---|---|---|---|---|
| APILAC | 107 258 | -23.7% | 56.8% | -5 | 41 089 785 | 0.4% | 80.8% | 0.3 |
| CAPSICAM | 924 153 | -20.6% | 3.2% | -0.3 | 381 694 177 | -5.4% | 3.5% | -0.2 |
| MILDRONATE | 4 228 142 | 13.3% | 63.9% | 0.1 | 1 713 110 479 | 21.0% | 68.8% | 1.4 |
| SULFARGIN | 142 016 | -24.8% | 0.8% | -0.2 | 68 999 573 | -11.1% | 1.1% | -0.1 |
| VIPROSAL | 1 061 459 | -16.0% | 3.6% | -0.1 | 399 585 258 | -5.8% | 3.7% | -0.2 |
| Brand | Volume | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. |
|---|---|---|---|---|---|---|---|---|
| APILAC | 123 351 | -23.4% | 57.3% | -4 | 46 431 180 | -0.5% | 80.9% | 0.8 |
| CAPSICAM | 1 088 294 | -20.1% | 3.3% | -0.3 | 449 472 537 | -3.3% | 3.6% | -0.1 |
| MILDRONATE | 4 778 564 | 13.1% | 63.4% | 0 | 1 949 376 898 | 22.2% | 68.5% | 1.6 |
| SULFARGIN | 162 640 | -21.7% | 0.8% | -0.2 | 78 557 277 | -7.4% | 1.2% | -0.1 |
| VIPROSAL | 1 222 932 | -15.9% | 3.7% | -0.2 | 461 918 444 | -3.7% | 3.7% | -0.1 |
## [1] "VIPROSAL"## [1] "VIPROSAL B UNGUENT FOR EXT USE 30 G #1"## [1] "VIPROSAL B UNGUENT FOR EXT USE 50 G #1"## [1] "VIPROSAL B UNGUENT FOR EXT USE 75 G #1"## [1] "VIPROSAL"## [1] "VIPROSAL B UNGUENT FOR EXT USE 30 G #1"## [1] "VIPROSAL B UNGUENT FOR EXT USE 50 G #1"## [1] "VIPROSAL B UNGUENT FOR EXT USE 75 G #1"## [1] "CAPSICAM"## [1] "CAPSICAM UNGUENT FOR EXT USE 30 G #1"## [1] "CAPSICAM UNGUENT FOR EXT USE 50 G #1"## [1] "CAPSICAM"## [1] "CAPSICAM UNGUENT FOR EXT USE 30 G #1"## [1] "CAPSICAM UNGUENT FOR EXT USE 50 G #1"## [1] "MILDRONATE"## [1] "MILDRONATE CAPS 250 MG #40"## [1] "MILDRONATE CAPS 500 MG #60"## [1] "MILDRONATE"## [1] "MILDRONATE CAPS 250 MG #40"## [1] "MILDRONATE CAPS 500 MG #60"## [1] "SULFARGIN"## [1] "SULFARGIN UNGUENT FOR EXT USE 1% 15 G #1"## [1] "SULFARGIN UNGUENT FOR EXT USE 1% 50 G #1"## [1] "SULFARGIN"## [1] "SULFARGIN UNGUENT FOR EXT USE 1% 15 G #1"## [1] "SULFARGIN UNGUENT FOR EXT USE 1% 50 G #1"## [1] "APILAC"## [1] "APILAC TABS 10 MG #25"## [1] "APILAC TABS 10 MG #50"## [1] "APILAC"## [1] "APILAC TABS 10 MG #25"## [1] "APILAC TABS 10 MG #50"